+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Animal Model Market Outlook to 2032

  • PDF Icon

    Report

  • 155 Pages
  • April 2022
  • Region: United States
  • Future Market Insights
  • ID: 5640803
This report on the animal model market offers a U.S. industry analysis for 2017-2021 and an opportunity assessment for 2022-2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the animal model market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the animal model market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the animal model market in the most comprehensive way for a better understanding of readers.

Key Segments of the Animal Model Market

This study on the animal model market offers information divided into four important segments - by species, by therapeutics, by application, and by end-user. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Species

  • Mouse
  • Rat
  • Cat
  • Dog
  • Rabbit
  • Pig
  • Monkey
  • Others

By Therapeutics

  • Metabolic Diseases
  • Cardiovascular Diseases
  • Neurological Diseases
  • Oncology

By Application

  • Drug Discovery/Development
  • Basic & Applied Research

By End User

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • CROs

Chapter 1 - Executive Summary

  • The report commences with the executive summary of the animal model market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the animal model market as well as the key trends affecting the market.

Chapter 2 - Market Overview

  • Readers can find detailed taxonomy and product definition/scope /limitations, inclusions, and exclusions of the animal model market in this chapter, which helps readers, understand basic information about the animal model.

Chapter 3 - Key Market Trends

  • This section highlights the key trends impacting the animal model market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 4 - Market Background

  • This chapter explains the key macroeconomic factors that are expected to influence the growth of the animal model market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the animal model market, which include the drivers, restraints, and opportunity analysis.

Chapter 5 - Key Success Factors

  • This section highlights the key success factors impacting the animal model market, which will help readers in understanding pestle analysis, porter’s analysis, application vs animal model intensity mapping, key strategies followed by manufacturers, supply chain analysis, an animal model in disease research, and regulatory scenario, that are expected to create a positive impact on the growth of the animal model market during the forecast period.

Chapter 6 - COVID-19 Crisis Analysis

  • This section provides the current and expected impact of COVID-19 on the animal model market.

Chapter 7 - U.S. Animal model Market Demand Analysis 2017-2021 and Forecast, 2022-2032

  • This section explains the U.S. market demand analysis and forecast for the animal model market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2021), and an incremental $ opportunity for the forecast period (2021-2031).

Chapter 8 - U.S. Animal model Market Analysis 2017-2021 and Forecast 2022-2032, by Species

  • Based on species, the animal model market is segmented into mice, rats, cats, dogs, rabbits, pigs, monkeys, and other species. In this chapter, readers can find information about a detailed analysis of the market by different solutions available in the animal model market and their growth over the forecast period.

Chapter 09 - U.S. Animal model Market Analysis 2017-2021 and Forecast 2022-2032, By Application

  • Based on application, the animal model market is segmented into drug discovery/development and basic & applied research. In this chapter, readers can find information about a detailed analysis of the market by different applications available in the animal model market and their growth over the forecast period.

Chapter 10 - U.S. Animal model Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutics

  • Based on therapeutics, the animal model market is segmented into metabolic diseases, cardiovascular diseases, neurological diseases, and oncology. In this chapter, readers can find information about a detailed analysis of the market by different solutions available in the animal model market and their growth over the forecast period.

Chapter 11 - U.S. Animal model Market Analysis 2017-2021 and Forecast 2022-2032, by End User

  • Based on end-users, the animal model market is segmented into academic & research institutes, pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and other end users. In this chapter, readers can find information about a detailed analysis of the market by different end user available in the animal model market and their growth over the forecast period.

Chapter 12 - Market Structure Analysis

  • This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the animal model market.

Chapter 13 - Competition Analysis

  • In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the animal model market including company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report include Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Inc., Genoway SA, Envigo CRS SA, Janvier Labs, Applied stem cells, Biocytogen, Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs), Cyagen, Ingenious targeting labs, Crown Bioscience Inc. (JSR Corporation), Harbour Biomed, Sinclair BioResources, Alpha Genesis Inc., Creative Animodel, and DaVinci Biomedical Research Products, Inc.

Chapter 14 - Assumptions and Acronyms Used

  • This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 15 - Research Methodology

  • This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the animal model market.

Table of Contents

1. Executive Summary
1.1. U.S. Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1.1. Key Trends Impacting The Market
3.1.2. Innovation/Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. U.S. GDP Growth Outlook
4.1.2. U.S. Healthcare Expenditure Outlook
4.1.3. U.S. Pharmaceutical Industry Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Increasing Intent of Academic & Research Institutions
4.2.2. Increasing Number Of Vaccine Testing and Development
4.2.3. Disease Prevalence and Growth
4.2.4. Rising Focus on Technological Advancements in Biotechnology
4.2.5. Increased Funding and Support from Government
4.2.6. Adoption Rate
4.2.7. Increasing Number of Clinical Trials
4.2.8. Increasing Preference for Customized Animal Models
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Key Success Factors
5.1. Application Vs Animal Model Intensity Mapping
5.2. Key Strategies by Manufacturers
5.3. PESTLE Analysis
5.4. Porters Analysis
5.5. Key Regulations
5.6. Supply Chain Analysis
5.7. Cost Structure
5.8. Type of Animal Model and Analysis thereof
5.9. Animal Model in Disease Research
5.10. Animal Model for Clinical Research
5.11. List of animal model suppliers in the U.S.
5.11.1. Small Animals
5.11.2. Large Animals
5.12. Animal model outlook in Boston
5.12.1. Market Size by Animal in Boston, 2021
5.12.2. Demand Trends
5.12.2.1. Small Animals
5.12.2.2. Large Animals
5.12.3. Animal Model Lab Layout
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.4.1. By Species
6.4.2. By Therapeutic Area
6.4.3. By Application
6.4.4. By End User
6.4.5. By Country
7. U.S. Animal Model Market Demand (US$ Million) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Million) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022-2032
7.2.1.1. Y-o-Y Growth Trend Analysis
7.2.1.2. Absolute $ Opportunity Analysis
8. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Species Introduction/Key Findings
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Million) Analysis by Species, 2017-2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Species, 2022-2032
8.3.1. Rats
8.3.2. Mice
8.3.3. Pig
8.3.4. Rabbits
8.3.5. Monkeys
8.3.6. Dogs
8.3.7. Cats
8.3.8. Other Species
8.4. Market Attractiveness Analysis by Species
9. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Application
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Million) Analysis by Application, 2017-2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2022-2032
9.3.1. Drug Discovery/Development
9.3.2. Basic and Applied Research
9.4. Market Attractiveness Analysis by Application
10. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Therapeutic Area
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Therapeutic Area, 2017-2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Therapeutic Area, 2022-2032
10.3.1. Metabolic Disease
10.3.2. Cardiovascular Disease
10.3.3. Neurologic Disease
10.3.4. Oncology
10.4. Market Attractiveness Analysis by Therapeutic Area
11. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by End User
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Million) Analysis by End User, 2017-2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2022-2032
11.3.1. Academic & Research Institutions
11.3.2. Pharmaceutical Companies
11.3.3. Biotechnology Companies
11.3.4. Contract Research Organizations (CROs)
11.3.5. Other End Users
11.4. Market Attractiveness Analysis by End User
12. Market Structure Analysis
12.1. Market Analysis by Tier of Companies
12.2. Market Concentration
12.3. Market Share Analysis of Top Players
13. Competition Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Competition Deep Dive
13.3.1. Charles River Laboratories International, Inc.
13.3.1.1. Overview
13.3.1.2. Product Portfolio
13.3.1.3. Strategy Overview
13.3.1.3.1. Marketing Overview
13.3.1.3.2. Product Strategy
13.3.1.3.3. Channel Strategy
13.3.2. The Jackson Laboratory
13.3.2.1. Overview
13.3.2.2. Product Portfolio
13.3.2.3. Strategy Overview
13.3.2.3.1. Marketing Overview
13.3.2.3.2. Product Strategy
13.3.2.3.3. Channel Strategy
13.3.3. Deerland Probiotics & Enzymes Inc.
13.3.3.1. Overview
13.3.3.2. Product Portfolio
13.3.3.3. Strategy Overview
13.3.3.3.1. Marketing Overview
13.3.3.3.2. Product Strategy
13.3.3.3.3. Channel Strategy
13.3.4. Trans Genic Inc.
13.3.4.1. Overview
13.3.4.2. Product Portfolio
13.3.4.3. Strategy Overview
13.3.4.3.1. Marketing Overview
13.3.4.3.2. Product Strategy
13.3.4.3.3. Channel Strategy
13.3.5. Taconic Biosciences, Inc.
13.3.5.1. Overview
13.3.5.2. Product Portfolio
13.3.5.3. Strategy Overview
13.3.5.3.1. Marketing Overview
13.3.5.3.2. Product Strategy
13.3.5.3.3. Channel Strategy
13.3.6. Genoway SA
13.3.6.1. Overview
13.3.6.2. Product Portfolio
13.3.6.3. Strategy Overview
13.3.6.3.1. Marketing Overview
13.3.6.3.2. Product Strategy
13.3.6.3.3. Channel Strategy
13.3.7. Crown Bioscience, Inc.
13.3.7.1. Overview
13.3.7.2. Product Portfolio
13.3.7.3. Strategy Overview
13.3.7.3.1. Marketing Overview
13.3.7.3.2. Product Strategy
13.3.7.3.3. Channel Strategy
13.3.8. Envigo CRS SA
13.3.8.1. Overview
13.3.8.2. Product Portfolio
13.3.8.3. Strategy Overview
13.3.8.3.1. Marketing Overview
13.3.8.3.2. Product Strategy
13.3.8.3.3. Channel Strategy
13.3.9. Transposagen Biopharmaceuticals, Inc.
13.3.9.1. Overview
13.3.9.2. Product Portfolio
13.3.9.3. Strategy Overview
13.3.9.3.1. Marketing Overview
13.3.9.3.2. Product Strategy
13.3.9.3.3. Channel Strategy
14. Assumptions and Acronyms Used15. Research Methodolog

Companies Mentioned

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation)
  • Harbour Biomed
  • Sinclair Bio Resources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc